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Abstract 
Objectives: The aim of this study was to investigate the prevalence of xerostomia among dental patients and explo-
re the possible risk factors and symptoms associated with this condition.
Study Design: The prevalence of xerostomia and its associations were investigated among patients (n=1132) who 
were visiting the department of oral medicine at shorish dental speciality in sulaimani city. The age range was bet-
ween 10-79 years. 512 (45.2%) of participants were males and 620 (54.8%) were females. The data collected were 
age, sex, systemic diseases, medications and habit of smoking. Logistic regression models to estimate odds ratios 
and 95% confidence intervals were used to investigate the association of xerostomia with age, systemic diseases 
and medications and Chi Square test was also used to analyze the data.
Results: Prevalence of xerostomia was 16.07%. Prevalence of xerostomia was significantly higher among females 
(19.51%) than males (11.91%) (P=0.001). The most common diseases with the highest prevalence of xerostomia 
were psychological disorders (57.14%) followed by diabetes mellitus (53.84%), neurological disorders (40%), 
thyroid disorders (37.5%) and hypertension (36.48%). The most common medication with the highest prevalen-
ce of xerostomia was antihistamine (66.66%) followed by psychotherapeutic medications (60%), pain medica-
tions (55.88%), endocrinologic  agents (51.21%), antidyslipidic agents (50%) and antihypertensive medication 
(38.98%).  Xerostomia was significantly associated with ageing (OR: 1.02, P=0.000), systemic diseases (OR: 2.80, 
P=0.000) and medications (OR: 5.17, P=0.000). There was a high prevalence of reported symptoms of xerostomia 
and these symptoms were more prevalent among females, prevalence of xerostomia was higher in heavy smoker 
patients (19.48%) than non smoker patients but not significantly (16.14%) (p= 0.44).
Conclusions: There was a high prevalence of xerostomia among dental patients;  xerostomia was significantly more 
prevalent among females and significantly associated with age, systemic diseases and medications; xerostomia 
adversely affects oral functions; dentist must be familial with sign and symptoms of xerostomia and can have an 
active role in the management of xerostomia and preventing or treating complications. 
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Introduction
Xerostomia is a common subjective complaint of dry-
ness in the mouth (1). Self-reported mouth dryness or 
xerostomia is commonly used in population studies since 
diagnosing hyposalivation by measurement of saliva flow 
rates is time-consuming. The amount of saliva needed 
for a person to experience oral discomfort is on a case by 
case basis and studies have shown that xerostomia and 
hyposalivation are not always closely related (2). Saliva 
is a complex and important body fluid that plays a signifi-
cant role in the lubrication and protection of oral mucosa, 
remineralization of teeth, digestion, phonation, taste sen-
sation, buffering action and clearance, and antibacterial 
activity therefore, this fluid is necessary for the integrity 
of the oral tissues and is critical for protection and main-
taining of oral and dental health (3). Xerostomia has re-
cently been shown to affect the oral health-related quality 
of life of those affected (4). The presence of xerostomia 
with a low or altered salivary flow may place patients at 
a higher risk of dental caries, gingivitis, erosion and ul-
ceration of mucosal tissues, oral candidiasis, dysgeusia 
and dysphagia (5). A reduction of saliva may lead to com-
plaints of dry mouth, halitosis and oral burning sensation. 
Other manifestations may include an increasing aversion 
to dry foods, difficulty with swallowing dry foods, or in-
creased need to sip or drink water when swallowing (6). 
The major causes of xerostomia among dental patients 
were the use of medications, and head and neck radiation 
therapy (7). Other possible causes of dry mouth include 
uncontrolled diabetes, chronic graft-versus-host disease, 
sjogren’s syndrome, vasculitis, dehydration, malnutrition, 
psychogenic conditions and immunodeficiencies (8). The 
evidence for chemotherapy or normal ageing as causative 
factors is still controversial (9). 
Prevalence of xerostomia was assessed in several other 
previous investigations in different regions throughout 
the world (9-11). This study was designed to investigate 
the prevalence of xerostomia among dental patients and 
explore the possible risk factors and symptoms associa-
ted with this condition.
Study Design 
A cross-sectional survey was carried out among patients 
(n=1200) who were visiting the department of oral medi-
cine at shorish dental speciality center in Sulaimani city 
along 4 successive months (January 2014-April 2014) for 
seeking dental treatment. This research was approved by 
the Committee of Ethics at research of the University of 
Sulaimani and Shorish health center. According to decla-
ration of Helsinki, signed consent forms were obtained 
from all participants before conducting the study (12).
Demographic information such as age and sex were ob-
tained from participants as well as information on the 
current medical status obtained utilizing in depth inter-
views; medical conditions were classified into 12 cate-
gories and questionnaire was used for each category and 
the questionnaires were as the following:
1-Do you have any gastrointestinal disorders?
2- Do you have any skeletal disorders?
3-Do you have or have you ever had any cardiovascular 
disorders such as heart problems, etc?
4- Do you have an endocrine disorders such as diabetes 
mellitus or thyroid disorders?
5- Do you have any hematologic disorders such as ane-
mia and or a bleeding problem ?
6- Do you have renal disorders such as renal stone, etc?
7- Do you have any allergies?
8- Have you ever had hepatitis, jaundice or liver disease?
9- Do you have or have you ever had any neurological 
disorders?
10- Do you have or have you ever had psychological disor-
ders such as depression, anxiety and or schizophrenia, etc?
11- Do you have or have you ever had respiratory disor-
ders such as asthma, etc?
12- Do you have any other conditions?
The response options for each questionnaire were ‘yes’ 
‘no’ or ‘not sure/maybe’. At the analysis stage, only tho-
se who had responded ‘yes’ and suffered from chronic 
diseases were designated as having medical condition 
and those who had responded ‘yes’ and suffered from 
acute condition were not designated as having medical 
condition. The participants were also asked about medi-
cations; “Are you taking any medication?” If yes, then 
the type of medications were recorded and only medica-
tions were currently used for long term treatment were 
included, medications that were used in the past or it 
is used symptomatically for short period of time were 
excluded from the study and they were classified into 14 
categories as follows: antihypertensive medication, en-
docrinologic agents, pain medication, antidyslipidemic 
agents, antiplatlets medication, gastrointestinal agents, 
nutritional therapeutics, neurological medications, car-
diovascular medication, psychotherapeutic medication, 
respiratory agents, antihistamine, anticoagulant medica-
tion, and others. 
In case of the patient was younger than 18 years old, 
the informed consent was obtained from parents and the 
parents were asked questionnaire including “Does your 
child have or have had any of the following conditions?” 
The twelve questions were explained to the parents and 
similarly the response options for each question were 
‘yes’  ‘no’ or ‘not sure/maybe’. At the analysis stage, 
only those who had responded ‘yes’ were designated as 
having medical condition as well as the parents were 
asked regarding medications including “Is your child 
taking any medication?” If yes, then the type of medica-
tion was recorded. 
The participants were asked about habit of smoking too; 
“do you smoke tobacco products?” If response option 
was yes, the following question was “how many cigaret-
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tes smoked per day? smoker patients were categorized 
into three groups: light smoker (<10 cigarettes/day), mo-
derate smoker (10-19 cigarettes/day), or heavy smoker 
(> or =20 cigarettes/day) based on number of cigarettes 
per day smoked (13).  “Former smoker” and “never been 
smoker” were defined as “nonsmokers” in data analy-
ses. Study members were asked the question “How often 
does your mouth feel dry?” (Response options ‘Always’ 
‘Frequently’ ‘Occasionally’ or ‘Never’). At the analysis 
stage, those who had responded ‘Always’ or ‘Frequently’ 
were designated as “xerostomic” (14,15). 
Questionnaires were used regarding symptoms of dry 
mouth which include the following:
1-Do you feel any oral lesion in your mouth?
2-Do you feel burning sensation in your mouth?
3-Do you have a bad breath or halitosis?
4-Do you feel lip cracking?
5-Do you feel difficulties and impairments related to 
speaking, swallowing and taste sensation?
6-Do you feel dryness in other areas of the body inclu-
ding the lip, throat, eye, nose, and the skin?
7-Do you feel you need to wake up to drink water?
8- Do you feel thirsty?
9- Do you feel difficulty eating dry food?
The response options for each questionnaire were ‘yes’ 
‘no’ or ‘do not know’. At the analysis stage, only those 
who had responded ‘yes’ were recorded.
In this study patients who were mentally retarded or were 
unable to answer questionnaire due to other conditions 
such as deafness etc were also excluded from the study. 
Statistical analysis was performed using SPSS program 
version 16. Associations between categorical variables 
were tested using chi-square test; logistic regression test 
was used to determine association between xerostomia 
and age, systemic diseases and medications. Statistical 
significance was set at P < 0.05.
Results
The sample comprised 1200 patients but 68 patients re-
jected to participate therefore the final number was 1132 
participants aged from 10-79 years. 512(45.22) of parti-
cipants were male and 620 (54.77) were female. Female 
to male ratio was 1,2:1 with mean age±SD=32.32±13.18. 
They were categorized into four age groups: less than 
twenty years, twenty to thirty nine years, forty to fifty 
nine years and equal and more than sixty years. More 
than half of participants (57.68) were in age group 20-39 
years and the smallest prevalence of participants were in 
age group equal and more than sixty years (4.24%) fo-
llowed by less than twenty years (15.63%). There were 
no statistically significant sex differences between each 
consecutive age groups (p>0.05).  
Prevalence of xerostomia was 16.07%. The prevalence 
of xerostomia was more or less linearly increased with 
increasing age with highest prevalence in the age group 
equal and more than sixty years (33.33) were it showed 
significantly higher prevalence of xerostomia than age 
group twenty to thirty nine years (14.70%). Logistic 
regression test showed statistically significant associa-
tion between age and developing xerostomia (OR: 1.02, 
P=0.000) and also when male and females were consi-
dered separately; among females logistic regression test 
showed statistically significant association between age 
and developing xerostomia (OR: 1.02, P=0.000); on the 
other hand  among males logistic regression test showed 
no association between xerostomia and age (OR: 1.00, 
P=0.34). Over all prevalence of xerostomia was sig-
nificantly higher among females (19.51%) than males 
(11.91%) (P=0.001) (Table 1). 
Age 
group
Sex All patients Patients 
reported
xerostomia
P-value
<20 Male 84(47.45) 12(14.28) 0.62
Female 93(52.54) 11(11.82)
Total 177(15.63) 23(12.99)
20-39 Male 283(43.33) 27(9.54) 0.001
Female 370(56.66) 69(18.64)
Total 653(57.68) 96(14.70)
40-59 Male 124(48.81) 17(13.70) 0.05
Female 130(51.18) 30(23.07)
Total 254(22.43) 47(18.50)
≥60 Male 21(43.75) 5(23.80) 0.21
Female 27(56.25) 11(40.74)
Total 48(4.24) 16(33.33)
Total Male 512(45.22) 61(11.91) 0.001
Female 620(54.77) 121(19.51)
Total 1132(100) 182(16.07)
Table 1. Prevalence of xerostomia according to age and sex.
The most common diseases with the highest prevalence 
of xerostomia were psychological disorders (57.14%) 
followed by diabetes mellitus (53.84%), neurological 
disorders (40%), thyroid disorders (37.5%) and hyper-
tension (36.48%). Prevalence of xerostomia was hig-
her among patients with diseases than patients without 
diseases in all disease categories except liver disorders 
and respiratory disorders; the difference were statistica-
lly significant (P<0.05) except hematological disorders, 
renal disorders, and allergy (P>0.05). Overall patients 
with diseases were three times more likely to report xe-
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Systemic diseases Xerostomia Odds Ratio
(95% CI)
P-value
No Yes
Gastrointestinal disorders No 831(85.40) 142(14.59) 973(85.95) 1 0.001
Yes 119(74.84) 40(25.15) 159(14.04) 1.9 (1.3-2.93)
Skeletal disorders
No 863(86.38) 136(13.61) 999(88.25) 1 0.000
Yes 87(65.41) 46(34.58) 133(11.74) 3.3 (2.2-5)
hypertension No 903(85.34) 155(14.65) 1058(93.46) 1 0.000
Yes 47(63.51) 27(36.48) 74(6.53) 3.3 (2-5.5)
Cardiovascular disorders No 909(84.95) 161(15.04) 1070(94.52) 1 0.000
Yes 41(66.12) 21(33.87) 62(5.47) 2.8 (1.6-5)
Diabetes mellitus No 932(85.26) 161(14.73) 1093(96.55) 1 0.000
Yes 18(46.15) 21(53.84) 39(3.44) 6.7 (3.5-12.9)
Thyroid disorders No 940(84.22) 176(15.77) 1116(98.58) 1 0.01
Yes 10(62.5) 6(37.5) 16(1.41) 3.2 (1.1-8.9
Hematologic disorders No 924(84.22) 173(15.77) 1097(96.90) 1 0.11
Yes 26(74.28) 9(25.71) 35(3.09) 1.8 (0.8-4)
Renal disorders No 926(84.10) 175(15.89) 1101(97.26 1 0.31
Yes 24(77.41) 7(22.58) 31(2.73) 1.5 (0.6-3.6)
Allergy  No 927(83.96) 177(16.03) 1104(97.52) 1 0.79
Yes 23(82.14) 5(17.85) 28(2.47) 1.3 (0.4-3)
Liver disorders No 939(83.83) 181(16.16) 1120(98.93) 1 0.46
Yes 11(91.66) 1(8.33) 12(1.06) 0.4 (0.06-3.6)
Neurological disorders No 944(84.13) 178(15.86) 1122(99.11) 1 0.03
Yes 6(60) 4(40) 10(0.88) 3.5 (0.9-12.6)
Psychological disorders No 947(84.55) 178(15.82) 1125(99.38) 1 0.003
Yes 3(42.85) 4(57.14) 7(0.61) 7 (1.5-31.9)
Respiratory disorders No 946(83.86) 182(16.13) 1128(99.64) 1 0.38
Yes 4(100) 0(00.00) 4(0.35 ----------------
Others No 911(84.82) 163(15.17) 1074(94.87) 1 0.000
Yes 39(67.24) 19(32.75) 58(5.12) 2.7 (1.5-4.8)
Total
No 653(89.08) 80(10.91) 733(64.75) 1 0.000
Yes 297(74.43) 102(25.56) 399(35.24) 2.8 (2-3.8)
Table 2. Comparison of prevalence of xerostomia between patients with medical condition and patients without medical condition.
rostomia (OR: 2.8, 95% CI 2-3.8) than patients without 
diseases. Logistic regression test showed statistically 
significant association between disease and xerostomia 
(OR: 2.80, P=0.000) (Table 2). 
The most common medication with the highest preva-
lence of xerostomia was antihistamine (66.66%) fo-
llowed by psychotherapeutic medications (60%), pain 
medications (55.88%), endocrinologic  agents (51.21%), 
antidyslipidic agents (50%), and antihypertensive medi-
cation (38.98%). 
Prevalence of xerostomia was higher among patients 
who were using medications than patients who were 
not using medications in all medication categories 
but only antihypertensive medication, endocrinologic 
agents, pain medication, antidyslipidemic agents, ps-
ychotherapeutic medication, and antihistamine were 
significantly showed higher prevalence of xerostomia 
than patients who were not using these medications. 
Overall patients who were using medications were five 
times more likely to report xerostomia ( OR: 5.1, 95% CI 
3.5-7.4) than patients who were not using medications. 
Logistic regression test showed statistically significant 
association between use of medications and xerostomia 
(OR: 5.17, P=0.000) (Table 3).
Prevalence of medical condition was increased signi-
ficantly with increasing age (P<0.001), (P=0.03 for 
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Medications Xerostomia Total Odds Ratio
(95% CI)
P-value
No Yes
Antihypertensive 
medication
No 914(85.18) 159(14.81) 1073(94.78) 1 0.000
Yes 36(61.01) 23(38.98) 59(5.21) 3.6 (2.1-6.3)
Endocrinologic  agents No 930(85.24) 161(14.75) 1091(96.37) 1 0.000
Yes 20(48.78) 21(51.21) 41(3.62) 6 (3.2-11.4)
Pain medication No 935(85.15) 163(14.84) 1098(96.99) 1 0.000
Yes 15(44.11) 19(55.88) 34(3.00) 7.2 (3.6-14.5)
Antidyslipidemic agents No 939(84.59) 171(15.40) 1110(98.05) 1 0.000
Yes 11(50) 11(50) 22(1.94) 5.4 (2.3-12.8)
Antiplatlets medication No 940(84.15) 177(15.84) 1117(98.67) 1 0.06
Yes 10(66.66) 5(33.33) 15(1.32) 2.6 (0.8-7.8)
Gastrointestinal  agents No 940(84.07) 178(15.92) 1118(98.76) 1 0.20
Yes 10(71.42) 4(28.57) 14(1.23) 2.1 (0.6-6.8)
Nutritional therapeutics No 943(84.04) 179(15.95) 1122(99.11) 1 0.22
Yes 7(70) 3(30) 10(0.88) 2.2 (0.5-8.8)
Neurological medications No 945(84.07) 179(15.92) 1124(99.29) 1 0.09
Yes 5(62.5) 3(37.5) 8(0.70) 3.1 (0.7-13.3)
Cardiovascular medication No 945(84) 180(16) 1125(99.38) 1 0.36
Yes 5(71.42) 2(28.57) 7(0.61) 5.1 (2.3-11.1)
Psychotherapeutic 
Medication 
No 948(84.11) 179(15.88) 1127(99.55) 1 0.007
Yes 2(40) 3(60) 5(0.44) 7.9 (1.3-47.8)
Respiratory agents No 946(83.86) 182(16.13) 1128(99.64) 1 0.38
Yes 4(100) 0(00.00) 4(0.35) ------------------
Antihistamine No 949(84.05) 180(15.94) 1129(99.73) 1 0.01
Yes 1(33.33) 2(66.66) 3(0.26) 10.5 (0.9-116.9)
Anticoagulant medication No 949(83.90) 182(16.09) 1131(99.91) 1 0.66
Yes 1(100) 0(00.00) 1(0.08) -----------------
Others No 928(84.05) 176(15.94) 1104(97.52) 1 0.43
Yes 22(78.57) 6(21.42) 28(2.47) 1.4 (0.5-3.5)
Total No 854(88.13) 115(11.86) 969(85.60) 1 0.000
Yes 96(58.89) 67(41.10) 163(14.39 5.1 (3.5-7.4)
Table 3. Comparison of prevalence of xerostomia between patients on medications and patients not on medications.
age group equal and more than sixty years versus age 
group forty to fifty nine years). Prevalence of medica-
tion use was increased significantly with increasing age 
(P<0.001) (Figs. 1,2). Prevalence of medical condition 
and medication use were significantly higher among fe-
males than males (P<0.001) (Figs. 1,2).
There was a high prevalence of reported symptoms 
among xerostomic patients. Prevalence of reported 
symptoms were higher among females than males ex-
cept self reported oral lesion, self perceived taste distur-
bance and dry lip but only self reported burning mouth 
was significantly higher among females (18.18%) than 
males (4.91%) (p=0.01) (Table 4).
Prevalence of xerostomia was higher in heavy smoker 
patients (19.48%) than non smoker patients but not sig-
nificantly (16.14%) (p= 0.44) (Fig. 3).
Discussion
Most studies on xerostomia have been carried out on com-
munity-dwelling or institutionalized adults, very few stu-
dies and data are available for people under age 50 years es-
pecially in very young populations. The present study was 
a cross-sectional evaluation of prevalence of xerostomia in 
a wide age- range from 10  to 79 years of age. 
This study investigated the prevalence of and risk factors 
of xerostomia among a large number of dental patients. 
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Fig. 1. Prevalence of medical conditions according to age and sex. ?
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Fig. 2. Prevalence of medication use according to age and sex.
In a systematic review in Scandinavia, the prevalence of 
xerostomia in the 13 articles ranged from 0.9% to 64.8% 
(16). In all articles, the xerostomia level was determined by 
asking subject specific questions about dry mouth. In this 
study prevalence of xerostomia was 16.07%. This result 
is comparable to other studies done by Hahnel et al. (10) 
(16%), Villa and  Abati (9) (19.6%) and it was less than that 
reported in another study done by So et al. (11) (70.1%). 
The variations in the prevalence of xerostomia in different 
studies may be because of many factors such as age, sex, 
sample size and methodology used to carry out the study 
including the number, the content of the questions, and the 
guidelines used for the diagnosis of xerostomia. 
In this study, as expected the prevalence of xerostomia 
was more or less linearly increased with increasing age 
with highest prevalence in the age group equal and more 
than sixty years were it showed significantly higher pre-
valence of xerostomia than age group twenty to thirty 
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Self reported symptoms of xerostomia Reported 
symptoms
Male Female p-value
Self reported oral lesion 46(25.27) 17(27.86) 29(23.96) 0.56
Self reported burning mouth 25(13.73) 3(4.91) 22(18.18) 0.01
self reported halitosis 98(53.84) 32(52.45) 66(54.54) 0.79
Self perceived taste disturbance 76(41.75) 26(42.62) 50(41.32) 0.86
Self perceived lip cracking 88(48.35) 25(40.98) 63(52.06) 0.15
Dry lip 142(78.02) 51(83.60) 91(75.20) 0.19
Dry throat 108(59.34) 33(54.09) 75(61.98) 0.30
Dry eye 21(11.53) 7(11.47) 14(11.57) 0.98
Dry nose 45(24.72) 14(22.95) 31(25.61) 0.69
Dry skin 95(52.19) 26(42.62) 69(57.02) 0.06
Wake up to drink water 73(40.10) 21(34.42) 52(42.97) 0.26
Feeling thirst 128(70.32) 41(67.21) 87(71.90) 0.51
Difficulty eating dry food 76(41.75) 24(39.34) 52(42.97) 0.63
Difficulty in swallowing 57(31.31) 14(22.95) 43(35.53) 0.08
Speech difficulties 51(28.02) 12(19.67) 39(32.23) 0.05
Table 4. Prevalence of reported symptoms among 182 patients reported xerostomia according to sex.
?
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11,11 10,71
19,48
0
5
10
15
20
25
Fig. 3. Prevalence of xerostomia according to habit of smoking.
nine years. Logistic regression test showed statistically 
significant association between age and developing xe-
rostomia. Similar result were reported in several other 
previous investigations (9,17,18).
In this study, the enlarged prevalence of xerostomia with 
increasing age may be because of significant raise in pre-
valence of medical condition and use of medication with 
increasing age. Other possible factors are age-related 
changes in the composition of saliva (19) and geriatric 
malnutrition (20).
Prevalence of xerostomia was significantly higher 
among females than males. Among females logistic re-
gression test showed statistically significant association 
between age and developing xerostomia but not among 
males. Similarly in the majority of the other studies fe-
male had experienced more symptoms of xerostomia 
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than male (17,18)  however, in a study by Murray et al. 
(15) no appreciable sex difference was observed. This 
might be related to the menopausal age of the women 
(21) in this regard, it has been suggested that both quan-
tity and quality of saliva will be influenced by the me-
nopause in women, thus being potentially important for 
xerostomia. Some studies on healthy women have re-
ported higher salivary secretion before menopause than 
after (22) whilst others did not find any difference (23). 
The different composition of saliva in peri- and post-
menopausal women has been suggested to be depending 
on the amount of oestrogen (24) and the fact that wo-
men tend to report higher pain intensity in general and 
are more expressive about their general illness condition 
(25). Additionally, dry mouth may be affected by psy-
chological status, such as anxiety and depression (26), 
as the prevalence of psychological symptoms or diseases 
were reported to be higher in women than in men (27). 
In this study, the higher prevalence of xerostomia among 
females than males may be because of significantly hig-
her prevalence of medical condition and use of medica-
tion among females than males.
There were several reports claiming that the main causes 
for xerostomia and hyposalivation were systematic di-
seases and medication (18,28) which also was supported 
in this study. 
In this study, logistic regression test showed xerostomia 
was significantly associated with systemic diseases; pa-
tients with diseases were three times more likely to re-
port xerostomia than patients without diseases and the 
most common diseases with the highest prevalence of 
xerostomia were psychological disorders followed by 
diabetes mellitus, neurological disorders, thyroid disor-
ders and hypertension. Similarly in another study done 
by Villa and Abati (9) individuals with nervous or men-
tal disorders reported highest prevalence of xerostomia.
Several drug groups such as antidepressants, anticholi-
nergetics and antihistamines have been associated with 
xerostomia in multiple studies (29).
In this study, logistic regression test showed xerostomia 
was significantly associated with medications; patients 
who were using medications were five times more likely 
to report xerostomia than patients who were not using 
medications and the most common medication with the 
highest prevalence of xerostomia was antihistamine fo-
llowed by psychotherapeutic medications, pain medica-
tions, endocrinologic  agents, antidyslipidic agents, and 
antihypertensive medication.
There was a high prevalence of reported symptoms among 
xerostomic patients; with some exceptions prevalence of 
reported symptoms were higher among females than ma-
les. These symptoms could be used for diagnostic criteria 
of oral dehydration and salivary gland hypo-function (30). 
The findings of this study suggest that patients suffering 
from xerostomia may experience dry lips, throat, eyes, 
skin and nose. These symptoms could alert the dentist 
to a more serious problem, such as Sjogren’s syndro-
me. Dentists may be the first health care providers to 
encounter the early signs of Sjogren’s syndrome there-
fore, they should be familiar with the manifestations of 
the disease and be prepared to take an active role in the 
diagnosis, management and treatment of the oral com-
plications and eventually consult a rheumatologist if the 
symptoms persist (9). 
Prevalence of xerostomia was higher in heavy smoker 
patients than non smoker patients but not significantly. 
Similarly in another study done by Villa and Abati (9) 
no significant association was observed between smo-
king and xerostomia; on the other hand majority of other 
studies showed significant association between smoking 
and xerostomia (17,18). 
In summary, the result of this study showed high pre-
valence of xerostomia among dental patients. Xerosto-
mia was significantly more prevalent among females 
and significantly associated with age, systemic diseases 
and medications. Xerostomia can have an adverse effect 
on oral functions such as taste sensation, swallowing, 
speech, etc, and it may negatively affect general well be-
ing and quality of life, and oral health. There was a high 
prevalence of reported symptoms of xerostomia among 
dental patients therefore these reported symptoms could 
be used for diagnosis of xerostomia; with some excep-
tions symptoms were more prevalent among females 
and were more prevalent among heavy smokers than non 
smokers although without statistical significance; dentist 
must take careful history and clinical examinations for 
management of xerostomia using a tailored approach to 
find patients main risk factors and preventing or mana-
ging complications.    
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